课题基金 / 基金详情

INVESTIGATION OF MU TRANSPOSITION IN VITRO

INVESTIGATION OF MU TRANSPOSITION IN VITRO
MU 转座的体外研究
批准号:
3282495
负责人:
NORMAN P. HIGGINS
金额:
$9.36万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-07-01 至 1986-06-30

项目摘要

项目成果

NORMAN P. HIGGINS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mu is a bacterial virus that uses genetic transposition to integrate and replicate its DNA. Mu is the most active transposable element known and during the lytic cycle Mu uses the E. coli replication machinery to transpose to 100 different sites in the bacterial chromosome within an hour. The viral elements necessary for transposition include DNA sequences at both ends of the virus and the products of Mu genes A and B. Our long range objective is to dissect the biochemical mechanism of Mu transposition. We recently developed an in vitro system for carrying out efficient Mu transposition-replication. We plan to use this in vitro system to characterize transposition intermediates and to purify Mu transposition proteins. In the course of these studies we will identify the origin(s) of Mu replication, define the mechanism of initiation of DNA synthesis at the origin, and determine the biochemical properties of the proteins that carry out transposition. The process of transposition is now recognized in the dissemination of drug resistance genes and plasmids in bacteria, in DNA rearrangements of prokaryotic and eukaryotic chromosomes, and in the developmental cycle of oncogenic viruses. However, the biological impact of genetic transposition is only beginning to be appreciated. These studies will significantly advance our knowledge of the functions of the proteins and genetic sequences involved in this phenomenon.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UAB Multi-user Fermentation Facility Upgrade
Long Range Interactions in Mu and Bacterial DNA
QUINOLONE GYRASE INHIBITORS FOR M TUBERCULOSIS
QUINOLONE GYRASE INHIBITORS FOR M TUBERCULOSIS
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: